HB1801 Combined Treatment of HER2-positive Breast Cancer
Clinical trial NCT07116824 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07116824
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-15
- Primary completion
- 2026-07-15
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.